Bio-Works Technologies AB (publ) (NGM:BIOWKS)

Market Cap	185.66M
Revenue (ttm)	46.43M
Net Income (ttm)	-29.78M
Shares Out	80.37M
EPS (ttm)	-0.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,280
Average Volume	61,595
Open	2.300
Previous Close	2.310
Day's Range	2.220 - 2.370
52-Week Range	0.720 - 3.560
Beta	1.17
RSI	41.76
Earnings Date	Nov 7, 2025

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 30
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: BIOWKS

Financial Performance

In 2024, Bio-Works Technologies AB's revenue was 30.49 million, a decrease of -30.55% compared to the previous year's 43.90 million. Losses were -37.36 million, -34.25% less than in 2023.